Literature DB >> 21675859

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.

Angela França1, Parag Aggarwal, Eugene V Barsov, Serguei V Kozlov, Marina A Dobrovolskaia, África González-Fernández.   

Abstract

AIMS: While numerous studies have reported on nanoparticle uptake by phagocytic cells, the mechanisms of this uptake are poorly understood. A metastudy of research focusing on biological particulate matter has postulated that nanoparticles cannot be phagocytosed and therefore must enter cells via pinocytosis. The purpose of this study was to identify the route(s) of uptake of gold nanoparticles in vitro and to determine if these route(s) depend on particle size. MATERIALS &
METHODS: The parent RAW264.7 cell line and its derivatives, transduced with a virus carrying siRNA to macrophage scavenger receptor A, were used as model phagocytes. Citrate-stabilized gold colloids were used as model nanoparticles. We used chemical inhibitors known to interfere with specific routes of particulate uptake. We developed multifocal light microscopy methods including multifocal stack analysis with NIH ImageJ software to analyze cell uptake.
RESULTS: Irrespective of size, gold nanoparticles are internalized by macrophages via multiple routes, including both phagocytosis and pinocytosis. If either route was blocked, the particles entered cells via the other route.
CONCLUSION: Gold nanoparticles with hydrodynamic sizes below 100 nm can be phagocytosed. Phagocytosis of anionic gold colloids by RAW264.7 cells is mediated by macrophage scavenger receptor A.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21675859      PMCID: PMC3912350          DOI: 10.2217/nnm.11.41

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  30 in total

Review 1.  Mechanisms of phagocytosis in macrophages.

Authors:  A Aderem; D M Underhill
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  Regulated portals of entry into the cell.

Authors:  Sean D Conner; Sandra L Schmid
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

3.  Time evolution of the nanoparticle protein corona.

Authors:  Eudald Casals; Tobias Pfaller; Albert Duschl; Gertie Janneke Oostingh; Victor Puntes
Journal:  ACS Nano       Date:  2010-07-27       Impact factor: 15.881

4.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview.

Authors:  Ravi Shukla; Vipul Bansal; Minakshi Chaudhary; Atanu Basu; Ramesh R Bhonde; Murali Sastry
Journal:  Langmuir       Date:  2005-11-08       Impact factor: 3.882

5.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

Authors:  B Devika Chithrani; Arezou A Ghazani; Warren C W Chan
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

6.  Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells.

Authors:  Tae Hee Kim; Hua Jin; Hyun Woo Kim; Myung-Haing Cho; Chong Su Cho
Journal:  Mol Cancer Ther       Date:  2006-07       Impact factor: 6.261

7.  Transferrin-mediated gold nanoparticle cellular uptake.

Authors:  Pei-Hui Yang; Xuesong Sun; Jen-Fu Chiu; Hongzhe Sun; Qing-Yu He
Journal:  Bioconjug Chem       Date:  2005 May-Jun       Impact factor: 4.774

8.  X-ray crystal structure of an anti-Buckminsterfullerene antibody fab fragment: biomolecular recognition of C(60).

Authors:  B C Braden; F A Goldbaum; B X Chen; A N Kirschner; S R Wilson; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

9.  Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics.

Authors:  B X Chen; S R Wilson; M Das; D J Coughlin; B F Erlanger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery.

Authors:  Giulio F Paciotti; Lonnie Myer; David Weinreich; Dan Goia; Nicolae Pavel; Richard E McLaughlin; Lawrence Tamarkin
Journal:  Drug Deliv       Date:  2004 May-Jun       Impact factor: 6.419

View more
  26 in total

Review 1.  Exploiting endocytosis for nanomedicines.

Authors:  Akin Akinc; Giuseppe Battaglia
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

2.  Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells.

Authors:  Krishnendu Saha; Sung Tae Kim; Bo Yan; Oscar R Miranda; Felix S Alfonso; Denis Shlosman; Vincent M Rotello
Journal:  Small       Date:  2012-09-13       Impact factor: 13.281

Review 3.  Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines.

Authors:  Marina A Dobrovolskaia; Scott E McNeil
Journal:  J Control Release       Date:  2013-06-03       Impact factor: 9.776

Review 4.  Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.

Authors:  Mauro Sousa de Almeida; Eva Susnik; Barbara Drasler; Patricia Taladriz-Blanco; Alke Petri-Fink; Barbara Rothen-Rutishauser
Journal:  Chem Soc Rev       Date:  2021-03-05       Impact factor: 54.564

5.  Critical Antileishmanial in vitro Effects of Highly Examined Gold Nanoparticles.

Authors:  Muzamil Yaqub Want; Priya Yadav; Rakin Khan; Garima Chouhan; Mohammad Islamuddin; Sheka Yagub Aloyouni; Asoke P Chattopadhyay; Suliman Yousef AlOmar; Farhat Afrin
Journal:  Int J Nanomedicine       Date:  2021-10-28

Review 6.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 7.  Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants.

Authors:  Joanna M Kreitinger; Celine A Beamer; David M Shepherd
Journal:  J Immunol       Date:  2016-04-15       Impact factor: 5.422

8.  Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV.

Authors:  David M Stevens; Pavan Adiseshaiah; Siva S K Dasa; Tim M Potter; Sarah L Skoczen; Kelsie S Snapp; Edward Cedrone; Nimit Patel; Kathleen Busman-Sahay; Elias P Rosen; Craig Sykes; Mackenzie Cottrell; Marina A Dobrovolskaia; Jacob D Estes; Angela D M Kashuba; Stephan T Stern
Journal:  Mol Pharm       Date:  2020-09-09       Impact factor: 4.939

9.  What NIR photodynamic activation offers molecular targeted nanomedicines: Perspectives into the conundrum of tumor specificity and selectivity.

Authors:  Chanda Bhandari; Mina Guirguis; N Anna Savan; Navadeep Shrivastava; Sabrina Oliveira; Tayyaba Hasan; Girgis Obaid
Journal:  Nano Today       Date:  2020-12-16       Impact factor: 20.722

Review 10.  Gold nanoparticle mediated cancer immunotherapy.

Authors:  Joao Paulo Mattos Almeida; Elizabeth Raquel Figueroa; Rebekah Anna Drezek
Journal:  Nanomedicine       Date:  2013-10-05       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.